Public biotechnology 2004—the numbers

被引：0
|
作者：
Riku Lähteenmäki
Stacy Lawrence
机构：
来源：
Nature Biotechnology | 2005年 / 23卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Last year, public biotech companies made gains in revenues and profits, but with stock markets lackluster and regulatory issues looming, future growth remains uncertain.
引用
收藏
页码：663 / 671
页数：8
相关论文
共 50 条
  • [1] Public biotechnology 2004 -: the numbers
    Lähteenmäki, R
    Lawrence, S
    NATURE BIOTECHNOLOGY, 2005, 23 (06) : 663 - 671
  • [2] Public biotechnology 2003—the numbers
    Riku Lähteenmäki
    Monya Baker
    Nature Biotechnology, 2004, 22 : 665 - 670
  • [3] Public biotechnology 2002 -: the numbers
    Lähteenmäki, R
    DeFrancesco, L
    NATURE BIOTECHNOLOGY, 2003, 21 (06) : 607 - 612
  • [4] Public biotechnology 2001—the numbers
    Riku Lähteenmäki
    Liz Fletcher
    Nature Biotechnology, 2002, 20 : 551 - 555
  • [5] Public biotechnology 2002—the numbers
    Riku Lähteenmäki
    Laura DeFrancesco
    Nature Biotechnology, 2003, 21 : 607 - 612
  • [6] Public biotechnology 2005—the numbers
    Riku Lähteenmäki
    Stacy Lawrence
    Nature Biotechnology, 2006, 24 : 625 - 634
  • [7] Public biotechnology 2001 -: the numbers
    Lähteenmäki, R
    Fletcher, L
    NATURE BIOTECHNOLOGY, 2002, 20 (06) : 551 - 555
  • [8] Public biotechnology 2003 -: the numbers
    Lähteenmäki, R
    Baker, M
    NATURE BIOTECHNOLOGY, 2004, 22 (06) : 665 - 670
  • [9] Public biotechnology 2005 -: the numbers
    Lähteenmäki, R
    Lawrence, S
    NATURE BIOTECHNOLOGY, 2006, 24 (06) : 625 - 634
  • [10] Genetic testing, biotechnology, and GMOs: A snapshot of public opinion, 2003 through 2004
    Alford, RL
    Morris, KE
    Rives, CM
    Scherer, SE
    Weinstock, G
    Gibbs, RA
    Ghonima, K
    Belcher, M
    Valdes, H
    Sumners, C
    Law, C
    Reiff, P
    GENETICS IN MEDICINE, 2005, 7 (06) : 454 - 455
12345